Nuclear Receptors and Endocrine Disorders

描述（由申请人提供）： 关于“核受体和内分泌疾病”的詹森研讨会将于2003年12月12-14日在俄亥俄州辛辛那提的辛辛那提大学医学院举行。本次研讨会的重点将是双重的：第一，提供一个互动的平台，分享在核受体领域的新发现，第二，促进建立研究人员和学员/开始研究人员之间的积极互动。自1966年发现雌激素受体以来，核受体领域取得了巨大的进展。由Sohaib Khan博士（辛辛那提）、John巴克斯特（加州大学旧金山分校）、Jan-Ake Gustafsson（卡罗林斯卡）、Benita Katzenellenbogen（UI）、John McLachlan（杜兰大学）、Suresh Mohla（NCI）和Bert O 'Malley（贝勒大学）组成的组委会为本次研讨会确定了一份著名发言人名单。这些演讲者将涵盖以下研究领域：NR的结构/功能;辅激活子/辅抑制子和转录;核受体/信号转导和癌症;内分泌干扰素。 该计划将包括口头和海报介绍。组委会将挑选几张青年调查员/学员的海报进行简短的口头介绍。将尽最大努力促进受训人员与常设调查员之间的互动。其中一个期望是，学员将带回他们的新的和创新的研究思路，为他们未来的计划对核受体。

DESCRIPTION (provided by applicant): The Jensen Symposium on "Nuclear Receptor and Endocrine Disorders" will be held on December 12-14, 2003 at the University of Cincinnati College of Medicine, Cincinnati, OH. The focus of this symposium will be two-fold: first, to provide an interactive platform for sharing the new discovery in the nuclear receptor field and secondly to promote a vigorous interaction between established investigators and trainees/beginning investigators. Since the discovery of estrogen receptor in 1966, enormous progress has been made in the nuclear receptor field. An organizing committee comprising of Drs. Sohaib Khan (Cincinnati), John Baxter (UCSF), Jan-Ake Gustafsson (Karolinska), Benita Katzenellenbogen (UI), John McLachlan (Tulane), Suresh Mohla (NCI) and Bert O'Malley (Baylor) has identified a list of prominent speakers for this symposium. These speakers will cover the following areas of research: Structure/Function of NRs; Coactivators/Corepressors and Transcription; Nuclear Receptors/Signal Transduction and Cancer; Endocrine Disrutors. The program will include oral and poster presentations. The organizing committee will select a few posters of young investigators/trainees for short oral presentations. Maximum effort will be made to promote interactions between the trainees and the established investigators. One of the expectations is that the trainees will carry back with them new and innovative research ideas for their future programs on the nuclear receptors.